Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating Expenses    
Research and development costs $ 807,661 $ 139,922
General and administrative expenses 483,955 94,018
Total operating expenses 1,291,616 233,940
Operating Loss (1,291,616) (233,940)
Other Income (Expense)    
Interest expense (87,740)
Interest income 1,024 1,498
Total other income (expense) (86,716) 1,498
Net Operating Loss Before Income Tax Benefit (1,378,332) (232,442)
Income Tax Benefit 281,534
Net Loss $ (1,096,798) $ (232,442)
Net Loss per Common Share - Basic and Diluted $ (0.03) $ (0.01)
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted 35,272,626 31,745,242